Condition

Cutaneous T Cell Lymphoma (1)

Peripheral T Cell Lymphoma (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

National Cancer Institute (NCI) (1)

Collaborator

Intervention

romidepsin (1)

Study Documents

Intervention Type

drug (1)

Funder Type

NIH (1)

Study Type

Interventional (1)

peripheral t cell lymphoma

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Australia, United States (Romidepsin)

Completed

Cutaneous T Cell Lymphoma
Peripheral T Cell Lymphoma

Romidepsin

Scottsdale, Arizona
+12 more

Apr 13, 2017